ImmunoCell-Array: A novel technology for pathway discovery and cell profiling

Expert Review of Proteomics

Volumn 4, Issue 5, 2007, Pages 609-616

  Giorgetti, Luca ^b,c   Zanardi, Andrea ^a   Venturini, Samuele ^a   Carbone, Roberta ^a  

^a Via Franco Russoli 3   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c Centro CIMAINA   (Italy)

Author keywords

Drug discovery; High content screening; Image analysis; Immunofluorescence; Microarray; Omics technology; Patient monitoring; Proteome profiling; Systems biology

Indexed keywords

DRUG RESPONSE; DRUG SCREENING; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOCELL ARRAY; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MASS SPECTROMETRY; PARAMETER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEOMICS; REVIEW; STANDARDIZATION; TECHNOLOGY;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOASSAY; PROTEOME; TISSUE ARRAY ANALYSIS;

EID: 35448958368     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.4.5.609     Document Type: Review

References (33)

1. Mohr S, Leikauf GD, Keith G, Rihn BH. Microarrays as cancer keys: an array of possibilities. J. Clin. Oncol. 20(14), 3165-3175 (2002). •• Comprehensive description of microarray application in cancer field.
2. Jones J, Libermann TA. Genomics of renal cell cancer: the biology behind and the therapy ahead. Clin. Cancer Res. 13(2 Pt 2), S685-S692 (2007).
3. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J. Health Econ. 22(2), 151-185 (2003).
4. Drews J. Stategic trends in the drug industry. Drug Discov. Today 8(9), 411-420 (2003). • Interesting perspective on the present and future of the drug discovery market in view of biotechnological innovations.
5. Butcher EC. Can cell systems biology rescue drug discovery? Nat. Rev. Drug Discov. 4(6), 461-467 (2005). •• Excellent review in which the relevance of a new framework for data interpretation in biology is emerging; data integration in systems biology approach is one of the most promising methods for the description of networks and phenotypes.
6. Kingsmore SF. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5(4), 310-320 (2006). •• Gives a very detailed description of current antibody array technology.
7. Cretich M, Damin F, Pirri G, Chiari M. Protein and peptide arrays: recent trends and new directions. Biomol. Eng. 23(2-3), 77-88 (2006).
8. Haab BB. Antibody arrays in cancer research. Mol. Cell. Proteomics 4(4), 377-383 (2005).
9. Liotta LA, Espina V, Mehta AI et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 3(4), 317-325 (2003). •• Provides an accurate description of a novel technology for profiling cancer patient cells.
10. Gulmann C, Sheehan KM, Kay EW, Liotta LA, Petricoin EF III. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J. Pathol. 208(5), 595-606 (2006).
11. Souchelnytskyi S. Bridging proteomics and systems biology: what are the roads to be traveled? Proteomics 5(16), 4123-4137 (2005).
12. Andersen JS, Lam YW, Leung AK et al. Nucleolar proteome dynamics. Nature 433(7021), 77-83 (2005).
13. Bouwmeester T, Bauch A, Ruffner H et al. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat. Cell Biol. 6(2), 97-105 (2004).
14. Jones RB, Gordus A, Krall JA, MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439(7073), 168-174 (2006). • Remarkable demonstration of the power of mass spectrometry methods in signaling pathways analysis.
15. Ahn NG, Shabb JB, Old WM, Resing KA. Achieving in-depth proteomics profiling by mass spectrometry. ACS Chem. Biol. 2(1), 39-52 (2007).
16. Irish JM, Kotecha N, Nolan GP. Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat. Rev. Cancer 6(2), 146-155 (2006). • Excellent review that underlines the relevance of single-cell analysis in phenotype screening and protein profiling.
17. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4(8), 648-655 (2004).
18. Zanardi A, Giorgetti L, Botrugno OA et al. Immunocell-array for molecular dissection of multiple signaling pathways in mammalian cells. Mol. Cell Proteomics 6(5), 939-947 (2007). •• First report showing an application of the novel technology of ImmunoCell-Array for proteome profiling in the context of mammalian cells.
19. Lang P, Yeow K, Nichols A, Scheer A. Cellular imaging in drug discovery. Nat. Rev. Drug Discov. 5(4), 343-356 (2006).
20. Perlman ZE, Slack MD, Feng Y et al. Multidimensional drug profiling by automated microscopy. Science 306(5699), 1194-1198 (2004). •• Brilliant report of how good statistical analysis of data, through imaging technology, is able to offer interpretative cues and novel results in drug screening.
21. Carpenter AE, Jones TR, Lamprecht MR et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7(10), R100 (2006). •• The first freeware software for automated imaging analysis for biologists.
22. Tanaka M, Bateman R, Rauh D et al. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol. 3(5), E128 (2005).
23. Abramoff M, Magelhaes P, Ram S. Image processing with ImageJ. Biophotonics Int. 11(7), 36-42 (2004).
24. Grubb RL, Calvert VS, Wulkuhle JD et al. Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 3(11), 2142-2146 (2003).
25. + AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 106(3), 899-902 (2005).
26. Stofega MR, Sanders LC, Gardiner EM, Bokoch GM. Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions. Mol. Biol. Cell 15(6), 2965-2977 (2004).
27. Jordan VC. Pak up your breast tumor - and grow! J. Natl Cancer Inst. 98(10), 657-659 (2006).
28. Harris AJ, Dial SL, Casciano DA. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mutat Res. 549(1-2), 79-99 (2004).
29. Heinloth AN, Irwin RD, Boorman GA et al. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 80(1), 193-202 (2004).
30. Koop R. Combinatorial biomarkers: from early toxicology assays to patient population profiling. Drug Discov. Today 10(11), 781-788 (2005).
31. Eisenstein M. Protein arrays: growing pains. Nature 444(7121), 959-962 (2006). Websites
32. Affymetrix www.affymetrix.com
33. Zeptosens www.zeptosens.com